Products of Biotecnoscience: Modified Living Beings Used in Health and Agriculture Activities - II

Abstract

This panel seeks to explore the translation processes of lab created non-human organisms, such as attenuated virus, OGM plants and animals. Humans have been manipulating nature in many ways for a long time, through the domestication of animals and the use of plants as medicines. However, recently, there have been changes in the scale and form of this manipulation. First, it was affected by the development of microbiology, immunology, biochemistry and genetics, as new fields of research and new ways of applying knowledge. Secondly, biotechnology is increasingly used to “make useful products or solve problems,” and these products are no longer predominantly used in laboratories but are entering the production lines and into our lives.

The manipulation of living beings in the environment and in individual bodies – be it dissemination, extermination or recreation – has been used in several initiatives, especially in public health and in agriculture. These practices create, by translation, completely new beings, such as attenuated viruses, transgenic insects and others.

In this panel we would like to receive papers which think about these products of biotechnoscience and their translation processes from the moment they gain materiality in laboratories, to their movements into other areas – such as surveillance services, health posts, hospitals, factories, offices of politicians and public managers and regulation committees – as well as the possibilities of participation of emergent concerned groups in these processes – social movements, patient associations among others.

Discussant

• Maria Cristina de Oliveira Cardoso, UFRJ - HCTE

Individual Presentations

• Mosquitoes as Technologies to Prevent Epidemics - Claudia Santos Turco, HCTE-UFRJ / FIOCRUZ; Eduardo Nazareth Paiva, EDUARDO NAZARETH PAIVA

• STS Interruptions in Industrial Bio-Production - Susan Molyneux-Hodgson, University of Exeter; Sally Atkinson, University of Exeter; Achim Rosemann, University of Warwick, UK

• Vaccine Risk Questioners: The Human Cost of Risk and the Acknowledgement of Subjectivity - Leea Thompson Fudge, Southern Methodist University

• A Chemical Regime for Biotech - Benjamin Raimbault, Institute For Research and Innovation in Society

Session Organizer

• Claudia Santos Turco, HCTE-UFRJ / FIOCRUZ